Mangoceuticals (MGRX) Short-Term Debt issuances (2024 - 2025)
Mangoceuticals recorded quarterly Short-Term Debt issuances of $75000.0 in Q4 2025, up 300.0% quarter-over-quarter from -$37500.0 in Q4 2024, and up 300.0% year-over-year from $18750.0 in Q4 2024.
Mangoceuticals' Short-Term Debt issuances history runs 2 years deep, the most recent figure standing at $75000.0 for Q4 2025.
- In Q4 2025, Short-Term Debt issuances rose 300.0% year-over-year to $75000.0; the TTM figure through Dec 2025 stood at $37500.0 (changed N/A YoY), while the FY2025 annual figure was $175000.0, up 16.67% from the prior year.
- Short-Term Debt issuances came in at $75000.0 for Q4 2025 at Mangoceuticals, up from -$37500.0 in the prior quarter.
- In the past five years, Short-Term Debt issuances ranged from a high of $75000.0 in Q4 2025 to a low of -$37500.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Mangoceuticals | 7.03 Mn | 6.84 Mn | 29,001.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75,000.00 |
| Dec 31, 2025 | 75,000.00 |
| Dec 31, 2024 | -37,500.00 |
| Dec 31, 2024 | -37,500.00 |